Dianthus Therapeutics, Inc. /DE/ ($DNTH)
Filing Information
| Accession Number | 0001778623-26-000009 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 14, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
30,000
Total Value
$272,550.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, General Counsel and Sec. | Common Stock | โ | Aug 13, 2026 | Exercise/Conversion | 15,000 | $18.17 | $272,550.00 | 15,000 | Direct | โ | View Details | |
SVP, General Counsel and Sec. | Stock Option (Right to Buy) | Derivative | Aug 13, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 73,240 | Direct | โ | View Details |